Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.080
+0.047 (2.29%)
Aug 22, 2025, 4:00 PM EDT
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 91 employees as of March 31, 2025. The number of employees increased by 9 or 10.98% compared to the previous year.
Employees
91
Change (1Y)
9
Growth (1Y)
10.98%
Revenue / Employee
$1,161,143
Profits / Employee
$8,857
Market Cap
66.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 91 | 9 | 10.98% |
| Mar 31, 2024 | 82 | -16 | -16.33% |
| Mar 31, 2023 | 98 | -2 | -2.00% |
| Mar 31, 2022 | 100 | 76 | 316.67% |
| Mar 31, 2017 | 24 | 2 | 9.09% |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Glass House Brands | 374 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| American Oncology Network | 1,914 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Medexus Pharmaceuticals News
- 10 days ago - Medexus Pharmaceuticals Inc. (MEDXF) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 18 days ago - Medexus Schedules First Fiscal Quarter 2026 Conference Call - Newsfile Corp
- 18 days ago - GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS's Fiscal Year 2026 - Newsfile Corp
- 2 months ago - Medexus Pharmaceuticals Inc. (MEDXF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States - Newsfile Corp
- 2 months ago - Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call - Newsfile Corp
- 4 months ago - Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada - Newsfile Corp